Meeting Three
Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
On July 16, 2001 a scientific meeting examining thimerosal-containing vaccines and neurodevelopmental outcomes was held at the Charles Hotel in Cambridge, Massachusetts.
The meeting transcript is now available. The transcript is also available through the Public Access Records Office.
Materials Reviewed by the Committee
A Public Access File (PAF) has been created for the Immunization Safety Review Committee, which includes most written materials submitted to the committee from persons who are not officers, employees, or agents of the National Academies. The PAF may be reviewed by making an appointment with the Public Access Records Office (PARO) of the National Academies. The attached list includes most of the PAF records related to the July 16-18 meeting on Thimerosal-containing Vaccines and Neurodevelopmental Outcomes. Note that the PAF for this activity is updated continuously and may not be complete at the time of posting. Please check with the PARO if you have any questions regarding the PAF.
Questions and Answers on the Toxicity of Ethylmercury
One of the issues considered during the Immunization Safety Review Committee's meeting on thimerosal and neurodevelopmental outcomes is the toxicity of ethylmercury. As one of its data gathering activities, the committee asked Dr. László Magos to answer questions regarding the toxicity of ethylmercury.
The committee wishes to note that this represents the views of Dr. Magos and does NOT necessarily reflect the conclusions the committee will draw when it deliberates at its July meeting. The committee further notes that this paper is one source of many that it will review in the course of its deliberations.